top
Search terms
Results 21 - 30 of 137 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 14
Ehjcvp

The most important public health goal in stroke prevention for patients with atrial fibrillation (AF) is to treat a larger proportion of patients with risk factors for stroke with oral ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Sean D. Pokorney, Christopher B. Granger

Date : 01/04/2015 Item size : 159100 bytes
Ehjcvp

In this issue of the journal, Jørgensen and co-workers report temporal changes in patient characteristics and pharmacotherapy in 156 496 patients referred for coronary angiography between 2000 and ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/07/2015 Item size : 94363 bytes
Ehjcvp

Oral anticoagulation (OAC) is recommended for patients with atrial fibrillation (AF) who are at risk of stroke.1 The CHA2DS2-VASc score, which encompassed a group of common co-morbidities for ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Jo Jo Hai, Hung-Fat Tse

Date : 01/04/2015 Item size : 156814 bytes
Ehjcvp

[...]our presence in MEDLINE will increase the visibility of, and interest for, the journal. [...]the editors and editorial board members feel very satisfied and confident for the future of the ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Stefan Agewall

Date : 01/10/2016 Item size : 112617 bytes
Ehjcvp

Non-steroidal anti-inflammatory drugs and incident atrial fibrillation Original Editorial url: http://ehjcvp.oxfordjournals.org/content/1/2/115 The Publisher regrets that the original Editorial was ...

European Heart Journal - Cardiovascular Pharmacotherapy, ERRATUM

Date : 01/07/2015 Item size : 89009 bytes
Ehjcvp

Introduction Dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a P2Y12 inhibitor, is recommended by guidelines for up to 12 months in patients with acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Articles, Gianluigi Savarese, Stefano Savonitto, Lars H. Lund, Stefania Paolillo, Caterina Marciano, Santo Dellegrottaglie, Antonio ...

Date : 01/10/2016 Item size : 333679 bytes
Ehjcvp

Atrial fibrillationIschaemic strokePreventionOral anticoagulationIntroduction Atrial fibrillation (AF) is an expanding epidemic,1 and ischaemic stroke due to cardioembolism remains a trademark ...

European Heart Journal - Cardiovascular Pharmacotherapy, Current Opinion, Thure Filskov Overvad, Peter Brønnum Nielsen, Gregory Y. H. Lip

Date : 12/08/2016 Item size : 256208 bytes
Ehjcvp

In this issue of the journal, Serebruany and co-workers report data from a study of clinical utilization of dual antiplatelet therapy (DAPT) in patients with renal impairment following percutaneous ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/07/2016 Item size : 96542 bytes
Ehjcvp

Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER The aim of this study was to use individual ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Articles, Björn W. Karlson, Olov Wiklund, Michael K. Palmer, Stephen J. Nicholls, Pia Lundman, Philip J. Barter

Date : 01/10/2016 Item size : 168264 bytes
Ehjcvp

Optimal handling of the healthy In the preventive section, the HOPE-3 (Heart Outcomes Prevention Evaluation 3) trial stole the limelight, first and foremost by strengthening faith in statinsthis time ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Manan Pareek, Deepak L. Bhatt

Date : 01/07/2016 Item size : 164372 bytes